We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWPPW
6901
DELISTED
Perella Weinberg Partners Warrant
PWPPW
-28
Closed
CRTD
6902
DELISTED
Creatd Inc. Common Stock
CRTD
-12,197
Closed -$9K
AXU
6903
DELISTED
Alexco Resource Corp
AXU
-200
Closed
WARR.U
6904
DELISTED
Warrior Technologies Acquisition Company Units,eachconsistingofoneshare ofClassAcommonstockandone-halfofone warrant
WARR.U
-1,454
Closed -$14K
ETAC
6905
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
-1,327
Closed -$13K
WARR
6906
DELISTED
Warrior Technologies Acquisition Company
WARR
-99
Closed -$1K
ACKIT
6907
DELISTED
Ackrell SPAC Partners I Co Subunits
ACKIT
-100
Closed -$1K
CTEK
6908
DELISTED
CynergisTek, Inc.
CTEK
-2,771
Closed -$3K
CRXTW
6909
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$0 ﹤0.01%
91
CRXT
6910
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
-620
Closed
POLY
6911
DELISTED
Plantronics, Inc.
POLY
-1,406
Closed -$56K
RVACU
6912
DELISTED
Riverview Acquisition Corp. Unit
RVACU
-177
Closed -$2K
FST.U
6913
DELISTED
FAST Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
FST.U
-408
Closed -$4K
ENDP
6914
DELISTED
Endo International plc
ENDP
$0 ﹤0.01%
442
-68,632
-99% -$31.7K
FST
6915
DELISTED
FAST Acquisition Corp.
FST
-797
Closed -$8K
SMED
6916
DELISTED
Sharps Compliance Corp
SMED
-2,436
Closed -$7K
IEFN
6917
DELISTED
iShares Evolved U.S. Financials ETF
IEFN
-16,632
Closed -$459K
IEIH
6918
DELISTED
iShares Evolved U.S. Innovative Healthcare ETF
IEIH
-52,874
Closed -$1.74M
IECS
6919
DELISTED
iShares Evolved U.S. Consumer Staples ETF
IECS
-33,049
Closed -$1.08M
IEHS
6920
DELISTED
iShares Evolved U.S. Healthcare Staples ETF
IEHS
-48,676
Closed -$1.87M
MIDF
6921
DELISTED
iShares MSCI USA Mid-Cap Multifactor ETF
MIDF
-26,991
Closed -$877K
IEME
6922
DELISTED
iShares Evolved U.S. Media and Entertainment ETF
IEME
-27,362
Closed -$682K
CDR
6923
DELISTED
Cedar Realty Trust, Inc
CDR
-377
Closed -$11K
BKEP
6924
DELISTED
Blueknight Energy Partners L.P.
BKEP
-223
Closed -$1K
TPTX
6925
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-4,941
Closed -$372K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.